0001209191-21-031567.txt : 20210511 0001209191-21-031567.hdr.sgml : 20210511 20210511145618 ACCESSION NUMBER: 0001209191-21-031567 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210507 FILED AS OF DATE: 20210511 DATE AS OF CHANGE: 20210511 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Todisco Joseph CENTRAL INDEX KEY: 0001774807 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38485 FILM NUMBER: 21910883 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD CITY: BRIDGEWATER STATE: NJ ZIP: 08807 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amneal Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001723128 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: BUSINESS PHONE: (908) 947-3120 MAIL ADDRESS: STREET 1: 400 CROSSING BOULEVARD STREET 2: 3RD FLOOR CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER COMPANY: FORMER CONFORMED NAME: Atlas Holdings, Inc. DATE OF NAME CHANGE: 20171117 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-07 0 0001723128 Amneal Pharmaceuticals, Inc. AMRX 0001774807 Todisco Joseph C/O AMNEAL PHARMACEUTICALS, INC. 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 0 1 0 0 Executive Vice President Class A Common Stock 2021-05-07 4 M 0 4441 A 284381 D Class A Common Stock 2021-05-07 4 F 0 1562 5.20 D 282819 D Restricted Stock Units 2021-05-07 4 M 0 4441 0.00 D Class A Common Stock 4441 4442 D Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units. On May 7, 2018, the reporting person was granted 17,766 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. /s/ Meredith Cook, Attorney-in-Fact 2021-05-11 EX-24 2 attachment1.htm EX-24 DOCUMENT

POWER OF ATTORNEY
	Know all by these presents, that the undersigned hereby constitutes and
appoints each of (i) the
General Counsel of Amneal Pharmaceuticals, Inc., a Delaware corporation (the
"Company") and who is
currently Stephen Manzano, (ii) the Associate General Counsel of the Company and
who is currently
Meredith Cook, and (iii) the Assistant Secretary of the Company and who is
currently Guy Chayoun, signing
singly, and their respective successors (including anyone serving in such
capacities on an interim or acting
basis), with full powers of substitution, as the undersigned's true and lawful
attorney-in-fact to:
1.	prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the U.S.
Securities and Exchange Commission (the "SEC") a Form ID, including amendments
thereto, and
any other documents necessary or appropriate to obtain codes and passwords
enabling the
undersigned to make electronic filings with the SEC of reports required by
Section 16(a) of the
Securities Exchange Act of 1934 or any rule or regulation of the SEC;
2.	execute for and on behalf of the undersigned, in the undersigned's capacity
as an officer and/or
director of the Company, and/or 10% holder of the Company's capital stock, Forms
3, 4, and 5 and
any amendments thereto in accordance with Section 16(a) of the Securities
Exchange Act of 1934
and the rules thereunder;
3.	do and perform any and all acts for and on behalf of the undersigned which
may be necessary or
desirable to complete and execute any such Form 3, 4, or 5, complete and execute
any amendment or
amendments thereto, and timely file such form with the SEC and any stock
exchange or similar
authority; and
4.	take any other action of any type whatsoever in connection with the foregoing
which, in the opinion
of such attorney-in-fact, may be of benefit to, in the best interest of, or
legally required by, the
undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of
the undersigned pursuant to this Power of Attorney shall be in such form and
shall contain such
terms and conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper
to be done in the exercise of
any of the rights and powers herein granted, as fully to all intents and
purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or
substitutes, shall lawfully do or cause to
be done by virtue of this power of attorney and the rights and powers herein
granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the
undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.
	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer
required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of
and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed
writing delivered to the
foregoing attorneys-in-fact.
	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this
8th day of April 2021.
						/s/ Joseph Todisco
						By: Joseph Todisco